ArticlePublished 31 May 2024
Advancements and Utilization of Smart Nanomedicine in Urinary Tract Tumors
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Urinary tract tumors present significant challenges in diagnosis and treatment, necessitating innovative approaches to improve therapeutic outcomes while minimizing side effects. Smart nanomedicine, with its targeted drug delivery and controlled release capabilities, has emerged as a promising solution for addressing these challenges. This review explores the advancements and utilization of smart nanomedicine in the context of urinary tract tumors. Diagnostic applications include targeted imaging, biosensors, and theranostic platforms, enabling early detection and personalized treatment planning. Therapeutic applications encompass targeted drug delivery, enhanced penetration, combination therapy, and stimuli-responsive release, offering improved efficacy and reduced toxicity. However, clinical translation faces challenges such as biocompatibility, formulation optimization, scalability, and clinical validation. Despite these challenges, smart nanomedicine holds great promise for revolutionizing the diagnosis and treatment of urinary tract tumors, paving the way for personalized and precision medicine approaches in oncology.
Keywords
Subjects
NanotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nanomedicine & Nanotechnology
- SubjectNanotechnology
- BylineArticles whose byline prints “Alberto Dalton”
